{{Rsnum
|rsid=932316
|Chromosome=6
|position=25640972
|Orientation=plus
|GMAF=0.1754
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.6 | 31.2 | 65.2
| HCB | 2.2 | 27.9 | 69.9
| JPT | 0.0 | 18.6 | 81.4
| YRI | 6.5 | 40.3 | 53.2
| ASW | 7.0 | 35.1 | 57.9
| CHB | 2.2 | 27.9 | 69.9
| CHD | 4.6 | 28.4 | 67.0
| GIH | 5.0 | 19.8 | 75.2
| LWK | 11.0 | 36.7 | 52.3
| MEX | 1.7 | 19.0 | 79.3
| MKK | 28.2 | 50.0 | 21.8
| TSI | 2.9 | 24.5 | 72.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19084217
|Trait=Serum markers of iron status
|Title=Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels
|RiskAllele=
|Pval=0.000009
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs932316
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19084217; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. (Initial Sample Size: 459 twin pairs; Replication Sample Size: NR); (Region: 6p22.2; Reported Gene(s): SCGN; Risk Allele: rs932316-?); (p-value= 0.000009).This variant is associated with Serum markers of iron status.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740123
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs932316
|overall_frequency_n=22
|overall_frequency_d=128
|overall_frequency=0.171875
|n_genomes=12
|n_genomes_annotated=0
|n_haplomes=12
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}